Navigation Links
NicOx' Naproxcinod ABPM Data Presented at American Heart Association
Date:11/7/2007

se compounds in the reverse order. Subjects received a 2 week placebo wash-out before and in between the active treatment periods. Eligible subjects were between 50 and 75 years of age, in order to be representative of the osteoarthritis population, and 71.8% were over 65 years of age. Eligible subjects had controlled hypertension, defined as SBP inferior to 150 mmHg and/or DBP inferior to 95 mmHg and were treated for their hypertension by drugs from no more than 2 different antihypertensive drug classes at stable doses at screening. Eligible patients were not current NSAID users.

ABPM involves using a portable device to independently measure and record blood pressure at frequent intervals over a 24-hour period with minimal disruption of the subject's daily activity. In this trial, a 24-hour ABPM was performed at the start and following each of the two active treatment periods. During the 24-hour period, blood pressure measurements were taken at 20-minute intervals between 6:00 am and 10:00 pm and every hour from 10:01 pm to 5:59 am. In total four 24-hour ABPM measurements were taken per subject.

About naproxcinod

Naproxcinod, NicOx' lead investigational product, is in phase 3 clinical development for the treatment of the signs and symptoms of osteoarthritis. Results from the first pivotal phase 3 study (the 301 study) showed that naproxcinod has superior efficacy compared to placebo and no detrimental effect on blood pressure, in contrast to the existing anti-inflammatory agent naproxen. The two remaining pivotal phase 3 trials for naproxcinod are currently ongoing (302 and 303) and patients are undergoing standardized blood pressure measurements at each visit to the treatment center in these studies (Office Blood Pressure Measurements, OBPM). The Company expects to report the 302 and 303 efficacy results in mid-2008 and will conduct a predefined statistical analysis on the pooled OBPM data from the three phase 3 studies (301, 302 and 303), follow
'/>"/>

SOURCE NicOx S.A.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
2. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
5. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
6. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
7. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
8. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
9. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
10. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 2014 Research and Markets has ... - Global Strategic Business Report" report to their ... markets for Pharmaceutical Contract Manufacturing in US$ Thousand by ... solutions), Solid Dosage Forms (Tablets and Capsules), and Liquid ... Ointments). The report provides separate comprehensive analytics ...
(Date:8/19/2014)... Aug. 19, 2014  Tokyo-based Atonarp Inc. announced ... round led by Walden Riverwood Ventures with participation ... of Atonarp,s Smart Spectrometer technology platform, which will ... has targeted the oil & gas and healthcare ... are excited to partner with Atonarp in pursuing ...
(Date:8/19/2014)... Research and Markets has announced the ... by Technology, by Application & by Region- Global Trends & ... The demand for membranes is estimated to increase at ... $29.31 billion Membrane technology was first commercialized in ... filtration and kidney dialysis. In modern times, membranes find extensive ...
Breaking Medicine Technology:Global Pharmaceutical Contract Manufacturing - Strategic Business Report 2014 2Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2
(Date:8/20/2014)... Kan. (PRWEB) August 20, 2014 B. ... exclusively to healthcare providers, has been retained to lead ... Good Shepherd Health Care System in Hermiston, Ore. The ... industry, B. E. Smith has recently placed more than ... Health Care System is a progressive, not-for-profit healthcare organization ...
(Date:8/20/2014)... 20, 2014 Inc. Magazine recently ... its 33rd annual Inc. 500|5000, an exclusive ranking ... represents the most comprehensive look at the most ... such as Yelp, Pandora, Timberland, Dell, Domino’s Pizza, ... early exposure as members of the Inc. 500|5000. ...
(Date:8/20/2014)... Ticketability.com has Theresa Caputo tickets ... The well-known medium has been thrilling many with her ... 19 cities, with tickets becoming available August 15. , ... are Albany, Baltimore, Trenton, Erie, Buffalo, Philadelphia, Charlotte, Houston, ... San Diego. The medium’s fans can obtain Theresa Caputo ...
(Date:8/20/2014)... 2014 The “Human Insulin Market ... Acting, Premixed), Modern Human Insulin (Rapid Acting, Long ... Novomix, Tresiba, Others) - Forecast to 2019” provides ... opportunities, current market trends,and strategies impacting the global ... forecasts of the revenue and share analysis. , ...
(Date:8/20/2014)... Los Angeles, CA (PRWEB) August 20, 2014 ... will honor the 2014 Emmy Award Nominees and Presenters at ... place on August 22nd and 23rd in Beverly Hills from ... enjoy gifts, refreshments and music by DJ Morgan Hildebrand. , ... charity fundraising and will feature several charities at the lounge. ...
Breaking Medicine News(10 mins):Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 3Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 3Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 2Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 4
... DENVER and GOLDEN, Colo., Feb. 4 ABR-Affinity,BioReagents, ... sciences,research community and exclusive supplier to Thermo Fisher ... Scientific National Sales,Meeting and Supplier Expo, held January ... Convention Center in San Antonio, Texas. With an ...
... magnets pose almost-fatal attractions when swallowed by kids, new report ... the story of a little boy who swallowed a magnet ... 4, of San Jose, Calif., swallowed two tiny magnets from ... spring. , After the first ingestion, he confessed to his ...
... Parkinson,s, Alzheimer,s and ... Certain Forms of Cancer, FOSTER CITY, ... since PLAYSTATION(R)3 (PS3(R)) took part,in Stanford University,s Folding@home(TM) project on March ... million users. This,equates to roughly 3,000 PS3 users registering for Folding@home ...
... Youth Display 642 Pairs of Shoes Symbolizing Deaths Caused ... Members of the,statewide youth advocacy group H.O.T. (Helping ... at the State Capitol Rotunda to,highlight the problem of ... pairs of shoes on the steps of the Capitol, ...
... have a pretty good idea why your husband or boyfriend ... study, the Stanford University School of Medicine researchers have shown ... is more activated in men than women during video-game play. ... more attracted to, and more likely to become ,hooked, on ...
... Forms Alliance With Veterinary News Network, MODESTO, ... in,veterinary hospital captive audience digital signage solutions and ... one of the,most comprehensive client education systems in ... partnering with emebaVet, bringing interesting,and accurate pet health ...
Cached Medicine News:Health News:ABR-Affinity BioReagents Participates in the 2008 Fisher Scientific Supplier Expo in San Antonio, Texas 2Health News:Toy Magnets Can be a Very Real Threat 2Health News:Toy Magnets Can be a Very Real Threat 3Health News:One Million PLAYSTATION(R)3 Users Participate in Folding@home Research Project 2Health News:One Million PLAYSTATION(R)3 Users Participate in Folding@home Research Project 3Health News:Video games activate reward regions of brain in men more than women, Stanford study finds 2Health News:Video games activate reward regions of brain in men more than women, Stanford study finds 3Health News:emebaVet, LLC Client Education System Gets Bigger and Better in 2008 2Health News:emebaVet, LLC Client Education System Gets Bigger and Better in 2008 3
ENDO STITCH™ Single Use Loading Units....
The ENDO CLOSE™ trocar site closure device has application in laparoscopic procedures for approximation of tissues and percutaneous suturing for closing incision sites....
This ENDOLOOP suture has a suture type - 0 PDSII and a 1.5 inch diameter....
... ligature inserted into a plastic tube. The plastic tube ... other. The suture protrudes from the narrow end and ... which becomes secure after the device is activated. The ... scored end of the plastic tube. The scored end ...
Medicine Products: